Filing metadata

Accession number
0001662170-26-000004
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Nov 12, 2026
Reporting period
Nov 09, 2026
Description
Insider transaction

Explore SEC Filings Hub